Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Fourth presidential debate
Enters transfer portal
Woman killed in shark attack
'Leave me alone'
Married in Mexico?
Addresses Perry's death
US factory orders drop
5 family members shot dead
Announces run for governor
Finishes at No. 1 for 8th time
Exits presidential race
Out of hospital, back in prison
Canceled after 3 seasons
To hear bankruptcy case
Makes runway debut
Announces 2024 tour
4 killed in Dallas shooting
Makes fifth NFL appearance
Reveals plan to retire
Skips window appearance
Historic $82 million deal
Ex-US ambassador arrested
Deadly Bronx apartment fire
Selling videos on Cameo
ENEC, TerraPower deal
Mazdzer sets luge retirement
May face $1.5 million in fines
Israel orders evacuations
CO2 emissions increase
Long-term contract extension
Retires from reggaeton
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
895 results
OHE
5d
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...
10d
Novartis Urges Court to Hand It Quick Win in Drug Price Battle
Medicare’s drug price negotiation program violates the Constitution and must be struck down, Novartis Pharmaceuticals said in ...
JD Supra8d
Are Drugmakers Gaming the Patent System?
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
4d
Why drugmakers are lobbying hard | Morning Newsletter
It was a huge defeat for Big Pharma when Congress and President Joe Biden enacted a law aimed in part at lowering ...
Chattanooga Times Free Press
2d
Medicare drug plan premiums rising in 2024
Medicare prescription drug plans, known as Medicare Part D, are separate private insurance plans that accord with Medicare ...
3don MSN
Big Pharma is ‘reeling’ over the Inflation Reduction Act. Now a Philly-area drugmaker is fighting back.
Merck has filed a lawsuit alleging the Inflation Reduction Act’s pharmaceutical price negotiation program for Medicare ...
Fierce Healthcare26d
CMS wants feedback on how Medicare drug negotiations should evolve. Researchers, advocates, drugmakers all have notes
In terms of therapeutic breakthroughs, Isasi suggested that the drug price negotiation program’s current structure is an effective deterrent from drugmakers’ low-impact profit chasing. “In ...
STAT
5d
White House official dings Bristol Myers Squibb for fighting off generic competition
A White House Domestic Policy Council deputy criticized Bristol Myers Squibb's efforts to fight off generic competition for a ...
Health Affairs7d
Arriving At A Fair Price In The Medicare Drug Price Negotiation Program: Considerations From Other Countries
Under the Inflation Reduction Act (IRA) of 2022, the Centers for Medicare and Medicaid Services (CMS) will begin negotiating drug prices for a subset of drugs in Medicare. In doing so, CMS must ...
C&EN1d
C&EN’s Year in Pharma 2023
Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...
17don MSN
The inescapable ad campaign for a wonky drug policy debate
A seven-figure, yearlong PhRMA ad campaign has taken a very wonky policy debate mainstream — and it's made a longtime actor a ...
Lexington Clipper Herald
4d
A timeline of climate change negotiations as COP28 starts in Dubai
Here is a timeline of climate change negotiations as COP28 starts in Dubai.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices